Abstract | RATIONALE: AIM: DESIGN: STUDY OUTCOME: The primary outcome measure is an improvement of three lines or more on the Snellen visual acuity chart, which signifies a doubling of the visual angle.
|
Authors | Celia S Chen, Andrew W Lee, Bruce Campbell, Mark Paine, Tien Lee, Clare Fraser, John Grigg, Romesh Markus, Keryn Williams, Doug J Coster |
Journal | International journal of stroke : official journal of the International Stroke Society
(Int J Stroke)
Vol. 6
Issue 1
Pg. 87-9
(Feb 2011)
ISSN: 1747-4949 [Electronic] United States |
PMID | 21205247
(Publication Type: Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © 2011 The Authors. International Journal of Stroke © 2011 World Stroke Organization. |
Chemical References |
- Plasminogen Activators
- Tissue Plasminogen Activator
|
Topics |
- Adult
- Computer Security
- Female
- Humans
- Injections, Intravenous
- Male
- Plasminogen Activators
(administration & dosage, therapeutic use)
- Recovery of Function
- Retinal Artery Occlusion
(drug therapy)
- Sample Size
- Thromboembolism
(complications)
- Tissue Plasminogen Activator
(administration & dosage, therapeutic use)
- Treatment Outcome
- Vision Disorders
(etiology)
- Vision, Ocular
- Visual Acuity
- Visual Fields
|